Carmen Ayuso

Prof. Dr. Carmen Ayuso

orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2007 in Brain
Verified
Journal Article
Open access
PDF file
PAPatrizia Amati-Bonneau
Patrizia Amati-Bonneau
MVMaria Lucia Valentino
Maria Lucia Valentino
PRPascal Reynier
Pascal Reynier
M. ESTHER GALLARDO PEREZM. ESTHER GALLARDO PEREZ
M. ESTHER GALLARDO PEREZ
BBBelén Bornstein
Belén Bornstein
Valerio CarelliValerio Carelli
Valerio Carelli
Mutations in OPA1, a dynamin-related GTPase involved in mitochondrial fusion, cristae organization and control of apoptosis, have been linked to non-syndromic optic neuropathy transmitted as an autosomal-dominant trait (DOA). We here report on eight patients from six independent families showing that mutations in the OPA1 gene can also be responsible for a syndromic form of DOA associated with sensorineural deafness, ataxia, axonal sensory-motor polyneuropathy, chronic progressive external ophthalmoplegia and mitochondrial myopathy with cytochrome c oxidase negative and Ragged Red Fibres. Most remarkably, we demonstrate that these patients all harboured multiple deletions of mitochondrial DNA (mtDNA) in their skeletal muscle, thus revealing an unrecognized role of the OPA1 protein in mtDNA stability. The five OPA1 mutations associated with these DOA ‘plus’ phenotypes were all mis-sense point mutations affecting highly conserved amino acid positions and the nuclear genes previously known to induce mtDNA multiple deletions such as POLG1, PEO1 (Twinkle) and SLC25A4 (ANT1) were ruled out. Our results show that certain OPA1 mutations exert a dominant negative effect responsible for multi-systemic disease, closely related to classical mitochondrial cytopathies, by a mechanism involving mtDNA instability.

22 February 2009 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SBSabina Benko
Sabina Benko
JFJudy A Fantes
Judy A Fantes
JAJeanne Amiel
Jeanne Amiel
DKDirk-Jan Kleinjan
Dirk-Jan Kleinjan
Sophie ThomasSophie Thomas
Sophie Thomas
SLStanislas Lyonnet
Stanislas Lyonnet

6 March 2012 in Neurology
Verified
Journal Article
Closed access
PDF file
JLJ.-M. Lee
J.-M. Lee
ERE.M. Ramos
E.M. Ramos
JLJ.-H. Lee
J.-H. Lee
TGT. Gillis
T. Gillis
JMJ.S. Mysore
J.S. Mysore
JGJ.F. Gusella
J.F. Gusella
Objective: Age at onset of diagnostic motor manifestations in Huntington disease (HD) is strongly correlated with an expanded CAG trinucleotide repeat. The length of the normal CAG repeat allele has been reported also to influence age at onset, in interaction with the expanded allele. Due to profound implications for disease mechanism and modification, we tested whether the normal allele, interaction between the expanded and normal alleles, or presence of a second expanded allele affects age at onset of HD motor signs. Methods: We modeled natural log-transformed age at onset as a function of CAG repeat lengths of expanded and normal alleles and their interaction by linear regression. Results: An apparently significant effect of interaction on age at motor onset among 4,068 subjects was dependent on a single outlier data point. A rigorous statistical analysis with a well-behaved dataset that conformed to the fundamental assumptions of linear regression (e.g., constant variance and normally distributed error) revealed significance only for the expanded CAG repeat, with no effect of the normal CAG repeat. Ten subjects with 2 expanded alleles showed an age at motor onset consistent with the length of the larger expanded allele. Conclusions: Normal allele CAG length, interaction between expanded and normal alleles, and presence of a second expanded allele do not influence age at onset of motor manifestations, indicating that the rate of HD pathogenesis leading to motor diagnosis is determined by a completely dominant action of the longest expanded allele and as yet unidentified genetic or environmental factors. Neurology® 2012;78:690–695

12 June 1998 in Science
Verified
Journal Article
Closed access
PDF file
JEJames D. Eudy
James D. Eudy
MWMichael D. Weston
Michael D. Weston
SYSuFang Yao
SuFang Yao
DHDenise M. Hoover
Denise M. Hoover
HHeidi Rehm
Heidi Rehm
JSJanos Sumegi
Janos Sumegi
Usher syndrome type IIa (OMIM 276901), an autosomal recessive disorder characterized by moderate to severe sensorineural hearing loss and progressive retinitis pigmentosa, maps to the long arm of human chromosome 1q41 between markers AFM268ZD1 and AFM144XF2. Three biologically important mutations in Usher syndrome type IIa patients were identified in a gene ( USH2A ) isolated from this critical region. The USH2A gene encodes a protein with a predicted size of 171.5 kilodaltons that has laminin epidermal growth factor and fibronectin type III motifs; these motifs are most commonly observed in proteins comprising components of the basal lamina and extracellular matrixes and in cell adhesion molecules.

1 January 1998 in Nature Genetics
Verified
Journal Article
Closed access
AMAmalia Martínez-Mir
Amalia Martínez-Mir
EPEva Paloma
Eva Paloma
RARando Allikmets
Rando Allikmets
CACarmen Ayuso
Carmen Ayuso
TRTeresa del Río
Teresa del Río
SBSusana Balcells
Susana Balcells

1 February 2010 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KNKonstantinos Nikopoulos
Konstantinos Nikopoulos
CGChristian Gilissen
Christian Gilissen
AHAlexander Hoischen
Alexander Hoischen
CNC. Erik van Nouhuys
C. Erik van Nouhuys
FBF. Nienke Boonstra
F. Nienke Boonstra
RCRob W.J. Collin
Rob W.J. Collin